Inspired by the book, 'Loveleen Tandan', director Danny Boyle produced the oscar-winning film we now know of as 'Slumdog Millionaire'. The story centers on a Mumbai teen who enters India's version of 'Who Wants to Be a Millionaire' and the moments in his upbringing in the slums of India which helped him become the first winner of a billion rupees. When this happens he is then accused of cheating because how is it possible for someone like Jamal to know the answers to such questions? Jamal Malik is dragged for a brutal questioning before he can answer his final question to win a million dollars. Thus he is promptly arrested, abused, and thoroughly investigated.



INTRODUCTION:
Duchenne muscular dystrophy (DMD) was first described by the French
neurologist Guillaume Benjamin Amand Duchenne in the 1860s, but until
the 1980s, little was known about the cause of any kind of muscular
dystrophy. In 1986, MDA-supported researchers identified a particular
gene on the X chromosome that, when flawed (or mutated), leads to DMD. In
1987, the protein associated with this gene was identified and named dystrophin.
Lack of the dystrophin protein in muscle cells causes them to be
fragile and easily damaged.DMD has an X-linked recessive inheritance
pattern and is passed on by the mother, who is referred to as acarrier. [A]
Muscular
dystrophy is a group of diseases that cause progressive weakness and
loss of muscle mass. In muscular dystrophy, abnormal genes (mutations)
interfere with the production of proteins needed to form healthy muscle.
Various forms of muscular dystrophy exist. Symptoms typically appear
during childhood and mostly in boys. Although
there is no cure, medications and therapy treatments help manage
symptoms and slow down the progression of the disease. The
main sign of muscular dystrophy is progressive muscle weakness.
Specific signs and symptoms begin at different ages and in different
muscle groups, depending on the type of muscular dystrophy. [A]



Duchenne
muscular dystrophy is the most common form of muscular dystrophy.
Although girls can be carriers and mildly affected, it's much more common in boys. About
one-third of boys with Duchenne muscular dystrophy (DMD) don't have a
family history of the disease, possibly because the gene involved may be
subject to sudden abnormal change (spontaneous mutation). Symptoms include Frequent falls, Difficulty rising from a lying or sitting up position, Trouble running and jumping, Waddling gait, Walking on the toes, Large calf muscles, Muscle pain and stiffness, and Learning disabilities.[A]
Some of the many forms of Muscular Dystrophy include Myotonic
(or 'Steinert's Disease' which is characterized by the inability to
relax muscles at will following contractions. Myotonic Muscular
Dystrophy is the most common form of adult-onset MD. Muscles in the face
and neck are affected first.), Facioscapulohumeral ("FSHD" muscles in face and shoulders weaken), Congenital (affects
both boys and girls. It is apparent at birth or before two years of
age. other sub-forms progress slowly and cause mild disability verses
others which progress rapidly, causing severe impairment), and Limb-Girdle
(hip and shoulder muscles affected first. experience difficulty lifting
front part of foot causing frequent trips while walking. onset usually
begins in childhood or teen years).[A]



BACKGROUND INFORMATION:
Muscular
dystrophy (MD) is a group of more than 30 inherited diseases. They all
cause muscle weakness and muscle loss. Some forms of MD appear in
infancy or childhood. Others may not appear until middle age or later.
The different types can vary in whom they affect, which muscles they
affect, and what the symptoms are. All forms of MD grow worse as the
person's muscles get weaker. Most people with MD eventually lose the
ability to walk. There is no cure for muscular dystrophy. Treatments can help with the
symptoms and prevent complications. They include physical and speech
therapy, orthopedic devices, surgery, and medications. Some people with
MD have mild cases that worsen slowly. Others cases are disabling and
severe. [B] For
diagnosis purposes physicians will begin with a medical history and
physical examination. Next patient may be recommended to take enzyme
tests, electromyography, genetic testing, muscle biopsy, heart-monitoring tests, and/or lung-monitoring tests. Damaged
muscles release enzymes, such as creatine kinase (CK), into your blood.
In a person who hasn't had a traumatic injury, high blood levels of CK
suggest a muscle disease — such as muscular dystrophy. This is why enzyme tests are recommended by physicians.[B]
With electromyography an
electrode needle is inserted into the muscle to be tested. Electrical
activity is measured as you relax and as you gently tighten the muscle.
Changes in the pattern of electrical activity can confirm a muscle
disease. Genetic testing such as blood samples check for possible mutations in some genes that cause different types of Muscular Dystrophy. Tests in which a small piece of muscle is removed by an incision or a hollow needle is known as muscle biopsy. An analysis of this biopsy of the tissue sample can distinguish
muscular dystrophies from other muscle diseases. Lastly, heart-monitoring tests check a patients heart function in particular those with myotonic muscular dystrophy.[B]
Although
there is no cure, treatments have been created to help prevent or
reduce joint or spinal problems. These treatments help patients remain
mobile as long as possible. Treatment options include medications,
physical and occupational therapy, and surgical or other procedures.[B]
Eteplirsen
(Exondys 51), the first medication to be approved by the Food and Drug
Administration specifically to treat Duchenne muscular dystrophy. It was
approved conditionally in 2016 and will continue to be evaluated during
an additional two years of use. Although
the medication appears safe, it's not clear how effective the drug is.
It's definitely not a cure for DMD, but it may increase muscle strength
in some people treated with the drug. Eteplirsen acts on specific gene
variants that affect approximately one in seven people with DMD. [B]


Corticosteroids
can strengthen muscles and delay certain types of MD. Prednisone is an
example of such corticosteroids. The con to such medications tend to
cause weight gain, weakened bones, and increase fracturing risks. Heart
medications, such as angiotensin-converting enzyme (ACE) inhibitors or
beta blockers, if muscular dystrophy damages the heart. [C]
Then there are the several types of therapy to choose from and available assistive devices which can improve quality of life. Muscular
dystrophy can restrict the flexibility and mobility of joints. Limbs
often draw inward and become fixed in that position. Range-of-motion
exercises can help to keep joints as flexible as possible.[C]
Low-impact
aerobic exercise, such as walking and swimming, can help maintain
strength, mobility and general health. Some types of strengthening
exercises also might be helpful. But it's important to talk to your
doctor first because some types of exercise might be harmful. Braces
can help keep muscles and tendons stretched and flexible, slowing the
progression of contractual. Braces can also aid mobility and function
by providing support for weakened muscles.[C]
Mobility aids such as canes, walkers and wheelchairs can help maintain mobility and independence. As
respiratory muscles weaken, a sleep apnea device may help improve
oxygen delivery during the night. Some people with severe muscular
dystrophy may need to use a machine that forces air in and out of their
lungs (ventilator). Surgery may be needed to correct a spinal curvature that could eventually make breathing more difficult.[C]



RESEARCH:
A
recent landmark study has successfully treated muscle wasting in
large mammals. These results have given both doctors and patients hope
in a new treatment for muscular dystrophy (most common genetic condition
in children that is ultimately fatal). Researchers
from this particular study were able to mend mutations which is also
cause the very same disease in dogs. Before the procedure is secured as
safe and effective for human patients much more work is needed in future
animal studies. They believe that a clinical trial involving patients with Duchenne muscular
dystrophy could be launched within a few years.[D]
Researchers
led by Eric Olson at the University of Texas Southwestern Medical
Center used a powerful but experimental gene-editing
procedure known as Crispr-Cas9 to correct mutations in the dystrophin
gene in four one-month-old dogs. The therapy uses harmless viruses to
smuggle the gene-editing molecules into cells. Once inside, they home in
on the mutated gene and cut it, causing the cell’s natural repair
system to swing into action.[D]




CONCLUSION:
The scientists went on to assess how well the procedure worked if it
was delivered by an infusion into the bloodstream instead of directly
into muscles. This time, two beagles were infused with either a high or
low dose of the Crispr gene editing molecules. Their muscle tissue was
examined eight weeks later.[D]
Researchers describe how the infusions had a variable effect on the
dogs’ muscles. In skeletal muscles, dystrophin was boosted by as little
as 3% to as much as 90% of normal levels. In crucial diaphragm and
heart muscles, dystrophin levels rose to 58% and 92% of normal levels
respectively. Discovering that intravenous delivery of the
virus resulted in significant restoration of dystrophin in the heart
and diaphragm muscles, which are important in this disease.[D]
The scientists now plan extensive studies to assess the impact of the
treatment on dogs. Those will reveal whether correcting the faulty
genes actually improves the animals’ muscles and whether any benefits
last. Because the study was small and run over a short time, it is
impossible to know how effective the approach might be at alleviating
the disease in humans.
This specific procedure is extremely promising based on our
preliminary findings, but more work is needed to ensure safety and to
determine long term durability of dystrophin expression. How soon it can be tested in humans depends on the results of
forthcoming long term studies in dogs that will carefully assess the
efficacy and safety of the procedure.
If everything were to continue smoothly, we might be able to
anticipate moving into a human trial in a few years, but caution is
paramount. Observing these advances in gene editing for Duchenne Muscular Dystrophy is very exciting, but limits to this study are real too.
The sample size was small and the study duration too short to know
whether the gene editing was safe and effective. Although it
seems to have largely boosted dystrophin production, which is key to
tackling this condition, the team weren’t looking to record improvements
in function. The next step will be to conduct larger, longer-term
studies to see if the gene-editing approach does help to slow the
progression of the condition and improve muscle strength. This won’t be a cure, but that shouldn’t obscure that this is a key
step forward in proving the Crispr-Cas9 technology could work for
Duchenne.[D]
LINKS:
[A] https://www.mayoclinic.org/diseases-conditions/muscular-dystrophy/symptoms-causes/syc-20375388
[B] https://medlineplus.gov/musculardystrophy.html
[C] https://www.mda.org/disease/duchenne-muscular-dystrophy
[D] https://www.theguardian.com/science/2018/aug/30/doctors-hail-breakthrough-in-muscular-dystrophy-treatment
[E] https://screenmusings.org/movie/blu-ray/Slumdog-Millionaire/index_4.htm
*Please note! These images are not mine. They were found on
various tumblr, pinterest, google image sites! If any are yours’ please let me
know so that I can give you credit for them! Also the people in the images have
no relation to the diseases, illnesses, or cancers I write about. Thanks so
much & enjoy~